First, pancreatic β cell dysfunction is controlled by a complex regulatory mechanism, and neither animal experiments nor human studies have been conducted to date to verify the effect of miR-574-3p on T2D by targeting PRMT1. Here, PRMT1 is linked to type 2 diabetes mellitus.